Christopher R. Reilly

570 total citations
10 papers, 122 citations indexed

About

Christopher R. Reilly is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, Christopher R. Reilly has authored 10 papers receiving a total of 122 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 3 papers in Genetics and 2 papers in Rheumatology. Recurrent topics in Christopher R. Reilly's work include Acute Myeloid Leukemia Research (4 papers), Platelet Disorders and Treatments (2 papers) and Telomeres, Telomerase, and Senescence (2 papers). Christopher R. Reilly is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Platelet Disorders and Treatments (2 papers) and Telomeres, Telomerase, and Senescence (2 papers). Christopher R. Reilly collaborates with scholars based in United States and United Kingdom. Christopher R. Reilly's co-authors include Akiko Shimamura, R. Coleman Lindsley, Suneet Agarwal, Neha Nagpal, Sioḃán Keel, Patrick Cahan, Yick W. Fong, Lauri M. Burroughs, Jing Zeng and Scot A. Wolfe and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Christopher R. Reilly

6 papers receiving 122 citations

Peers

Christopher R. Reilly
Kalin Mayberry United States
Danielle Townsley United States
Alicia Ellison United Kingdom
Lorien Shakib United States
Kalin Mayberry United States
Christopher R. Reilly
Citations per year, relative to Christopher R. Reilly Christopher R. Reilly (= 1×) peers Kalin Mayberry

Countries citing papers authored by Christopher R. Reilly

Since Specialization
Citations

This map shows the geographic impact of Christopher R. Reilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher R. Reilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher R. Reilly more than expected).

Fields of papers citing papers by Christopher R. Reilly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher R. Reilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher R. Reilly. The network helps show where Christopher R. Reilly may publish in the future.

Co-authorship network of co-authors of Christopher R. Reilly

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher R. Reilly. A scholar is included among the top collaborators of Christopher R. Reilly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher R. Reilly. Christopher R. Reilly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Weller, Edie, Marian H. Harris, Christopher R. Reilly, et al.. (2025). Lymphoid malignancies in patients with Shwachman-Diamond syndrome. Blood. 145(21). 2528–2532.
2.
Wahlster, Lara, Lucy A. Godley, Jason X. Cheng, et al.. (2025). ANKRD26-related thrombocytopenia 2 with a baseline increase in blasts: implications for clinical surveillance. Blood. 146(2). 254–259.
3.
Myers, Kasiani C., et al.. (2025). CONCORDANCE OF SOMATIC GENETIC TESTING IN BLOOD VS. BONE MARROW IN SHWACHMAN-DIAMOND SYNDROME. SHILAP Revista de lepidopterología. 6. 100332–100332.
4.
Wahlster, Lara, Jared H. Rowe, Nina Weichert‐Leahey, et al.. (2024). Expanding the Morphologic Spectrum of ANKRD26-Related Thrombocytopenia-2: A Case Series. Blood. 144(Supplement 1). 5708–5708.
5.
Shimony, Shai, H. Moses Murdock, Christopher R. Reilly, et al.. (2024). AML-MR Mutations Drive the Benefit of CPX-351 over 7+3 in the Pivotal Phase 3 AML Trial. Blood. 144(Supplement 1). 60–60. 2 indexed citations
6.
Weber, Brittany, et al.. (2023). A Race to the Finish. New England Journal of Medicine. 389(5). 455–462. 1 indexed citations
7.
Reilly, Christopher R. & Akiko Shimamura. (2022). Predisposition to myeloid malignancies in Shwachman-Diamond syndrome: biological insights and clinical advances. Blood. 141(13). 1513–1523. 29 indexed citations
8.
Egeren, Debra Van, Shichen Liu, Maximilian Nguyen, et al.. (2021). Transcriptional differences between JAK2-V617F and wild-type bone marrow cells in patients with myeloproliferative neoplasms. Experimental Hematology. 107. 14–19. 8 indexed citations
9.
Myllymäki, Mikko, Robert Redd, Christopher R. Reilly, et al.. (2020). Short telomere length predicts nonrelapse mortality after stem cell transplantation for myelodysplastic syndrome. Blood. 136(26). 3070–3081. 23 indexed citations
10.
Nagpal, Neha, Jing Zeng, Kevin Luk, et al.. (2020). Small-Molecule PAPD5 Inhibitors Restore Telomerase Activity in Patient Stem Cells. Cell stem cell. 26(6). 896–909.e8. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026